<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ortelli L</submitter><funding>Advisory Board Research Ente Ospedaliero Cantonale</funding><funding>Verein fur Krebsforschung</funding><pagination>733</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6042390</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Quality of cancer care (QoCC) has become an important item for providers, regulators and purchasers of care worldwide. Aim of this study is to present the results of some evidence-based quality indicators (QI) for prostate cancer (PC) at the population-based level and to compare the outcomes with data available in the literature.&lt;h4>Methods&lt;/h4>The study included all PC diagnosed on a three years period analysis (01.01.2011-31.12.2013) in the population of Canton Ticino (Southern Switzerland) extracted from the Ticino Cancer Registry database. 13 QI, approved through the validated Delphi methodology, were calculated using the "available case" approach: 2 for diagnosis, 4 for pathology, 6 for treatment and 1 for outcome. The selection of the computed QI was based on the a</pubmed_abstract><journal>BMC cancer</journal><pubmed_title>Quality indicators of clinical cancer care for prostate cancer: a population-based study in southern Switzerland.</pubmed_title><pmcid>PMC6042390</pmcid><funding_grant_id>KFS - 02668-08-2010</funding_grant_id><funding_grant_id>ABREOC 10/2010</funding_grant_id><pubmed_authors>Ortelli L</pubmed_authors><pubmed_authors>Mazzucchelli L</pubmed_authors><pubmed_authors>Bordoni A</pubmed_authors><pubmed_authors>Spitale A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Quality indicators of clinical cancer care for prostate cancer: a population-based study in southern Switzerland.</name><description>&lt;h4>Background&lt;/h4>Quality of cancer care (QoCC) has become an important item for providers, regulators and purchasers of care worldwide. Aim of this study is to present the results of some evidence-based quality indicators (QI) for prostate cancer (PC) at the population-based level and to compare the outcomes with data available in the literature.&lt;h4>Methods&lt;/h4>The study included all PC diagnosed on a three years period analysis (01.01.2011-31.12.2013) in the population of Canton Ticino (Southern Switzerland) extracted from the Ticino Cancer Registry database. 13 QI, approved through the validated Delphi methodology, were calculated using the "available case" approach: 2 for diagnosis, 4 for pathology, 6 for treatment and 1 for outcome. The selection of the computed QI was based on the a</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Jul</publication><modification>2025-04-04T18:42:01.484Z</modification><creation>2019-03-26T23:46:18Z</creation></dates><accession>S-EPMC6042390</accession><cross_references><pubmed>29996904</pubmed><doi>10.1186/s12885-018-4604-2</doi></cross_references></HashMap>